Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Impact of platelet inhibition on chronic hepatitis C
2008-002060-34Phase 2Completed
- Sponsor
- Medical University of Vienna
- Start
- Oct 2008
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in hepatitis C virus infection comparing Aspirin + clopidogrel + cilostazol, Dabigatran etexilate and Placebo (3 arms). Primary endpoint: ALAT level after 1 month of treatment. Started Oct 2008; status: completed.
02
Drugs
clopidogrelaspirincilostazoldabigatran
03
Conditions
hepatitis C virus infection
Beyond the preview
Go deeper on 2008-002060-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-002060-34.